Turnstone Biologics to be acquired by XOMA Royalty

1 week ago 1

• Healthcare
• M&A

• XOMA Royalty (NASDAQ:XOMA), a biotech royalty acquirer based in Emeryville, California, has agreed to buy cancer drug developer Turnstone Biologics (NASDAQ:TSBX) for $0.34 per share in cash plus a contingent value right (CVR), the companies announced Friday.
• The merger transaction has

Recommended For You

More Trending News

See More »

1. Homepage
2. Politics
3. Turnstone Biologics to be acquired by XOMA Royalty